Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect
HERALD of North-Western State Medical University named after I.I. Mechnikov · 31.03.2026 · 18 (1) · 52-60
DOI: 10.17816/mechnikov699041 ↗Kurz gefasst
Fachartikel in der Zeitschrift HERALD of North-Western State Medical University named after I.I. Mechnikov, online erschienen am 31.03.2026. Verfasst von Olga V. Teplyakova und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Knee osteoarthritis is the most common condition encountered in the practice of a rheumatologist. Given the high comorbidity of patients with osteoarthritis, local injectable therapy may be chosen as a treatment strategy for such patients. One of the promising directions in the development of local injectable therapy for knee osteoarthritis is intra-articular collagen injections. AIM: Assessment of the safety and efficacy of injections of the medical device Compositron® 2 in the treatment of knee osteoarthritis, as well as a description of the phenotypic features of patients who achieved the best response to local injectable therapy for osteoarthritis. METHODS: The prospective study included 30 women with stage II osteoarthritis and a stable disease course. None of the study participants had received intra-articular injections during the previous 6 months. All patients received three intra-articular injections of Compositron® 2 on days 1, 15, and 45 of the study. The treatment efficacy was assessed using the KOOS (Knee injury and Osteoarthritis Outcome Score) scale. RESULTS: The study results demonstrated high efficacy of Compositron® 2 injections in knee osteoarthritis: in 70% of patients, the total KOOS score increased by the 6th month of follow-up. During therapy, 80% of patients reported a reduction in disease symptoms and improvement in daily activity, 73.3% reported pain reduction, 53.3% reported an increase in sports activity, and 70% reported an improvement in quality of life. A faster response to therapy was observed in patients with a high level of anxiety (HADS), without obesity, and with a high level of pain catastrophizing (PCS scale), but after a 3-month follow-up period, improvement was seen in all patient groups. None of the study participants reported adverse events or withdrew from the study. CONCLUSION: Compositron® 2 may be considered as an effective adjuvant agent for the treatment of knee osteoarthritis.
Zitieren
APA
Teplyakova, O. V., & Tsvetkova, O. G. (2026). Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect. HERALD of North-Western State Medical University named after I.I. Mechnikov, 18(1), 52-60. https://doi.org/10.17816/mechnikov699041
Vancouver
Teplyakova OV, Tsvetkova OG. Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect. HERALD of North-Western State Medical University named after I.I. Mechnikov. 2026;18(1):52-60. doi:10.17816/mechnikov699041
BibTeX
@article{Teplyakova2026,
author = {Teplyakova, Olga V. and Tsvetkova, Olga G.},
title = {Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect},
journal = {HERALD of North-Western State Medical University named after I.I. Mechnikov},
year = {2026},
volume = {18},
number = {1},
pages = {52--60},
doi = {10.17816/mechnikov699041}
}
EUVIMED